Computer-aided detection (CAD) firm iCAD has received clearance from the U.S. Food and Drug Administration (FDA) for its interventional planning package for breast MRI, the Nashua, NH-based company said.
iCAD's PrecisionPoint module will be offered with the company's CADvue breast MRI image review software. PrecisionPoint helps users find exactly where a biopsy is needed without having to manually calculate the location and depth of the lesion, according to iCAD.
Related Reading
iCAD launches CT colon CAD package, March 5, 2009
iCAD posts record 2008 results, February 26, 2009
iCAD debuts SecondLook with Planmed FFDM, December 31, 2008
iCAD supports Agfa CR in Europe, December 29, 2008
iCAD expands CAD portfolio, December 1, 2008
Copyright © 2009 AuntMinnie.com
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
